Verastem: FDA Grants New Mesothelioma Orphan Drug Approval to VS-5584
Drugmaker Verastem said the FDA granted its VS-5584 anti-cancer drug approval for treating mesothelioma, raising hopes for patients of the deadly cancer.
Drugmaker Verastem said the FDA granted its VS-5584 anti-cancer drug approval for treating mesothelioma, raising hopes for patients of the deadly cancer.
The new mesothelioma cases in Minnesota raise the total number of confirmed diagnoses to 101 among thousands of taconite mine workers.
New study shows an unusual number of mesothelioma cases among women and younger residents in southern Nevada may be linked to naturally occurring asbestos.
Two mesothelioma survivors spoke at Baylor College of Medicine President’s Circle, endorsing Dr. David Sugarbaker and the goals of the Lung Institute.
Surgical oncologist Dr. Suzanne Schiffman’s peritoneal mesothelioma experience lifts Allegheny’s reputation as rising cancer treatment center in Pittsburgh.
A clinical trial in the U.K. is testing the value of post-surgery radiotherapy in reducing new tumor growth in areas where surgeons make their incisions.
While developing countries ignore the dangers of asbestos, millions of people remain at risk of developing deadly mesothelioma in the coming years.
Researchers will test how effectively defectanib (VS-6063) can kill mesothelioma stem cells in expansive, ongoing clinical trial.
Dr. Raja Flores, a mesothelioma specialist at Mount Sinai Hospital, advocates the use of pleurectomy/decortication over more aggressive EPP surgery.
Mesothelioma patients undergoing improved Intensity Modulated Radiation Therapy and lung-sparing pleurectomy/decortication surgery are living longer lives.
Mesothelioma patients undergoing improved Intensity Modulated Radiation Therapy and lung-sparing pleurectomy/decortication surgery are living longer lives.
The son of a U.S. Marine Corps veteran who died of mesothelioma says the U.S. Veterans Health Administration is to blame for his father’s death.
Dr. Rodney Landreneau plans to redefine mesothelioma treatment as co-director of Esophageal and Lung Institute at Allegheny General Hospital
Researchers conducting multicenter clinical trials using nintedanib, known by its brand name Ofev, say the new drug may relieve mesothelioma symptoms.
A study of taconite workers in Minnesota’s Iron Range showed they were at higher risk of developing mesothelioma and heart disease.